ETON
Eton Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$689.75M
P/E Ratio
—
EPS
$-0.17
Beta
0.97
52W High
$27.29
52W Low
$13.09
50-Day MA
$20.61
200-Day MA
$17.81
Dividend Yield
—
Profit Margin
-5.76%
Forward P/E
24.10
PEG Ratio
—
About Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
Fundamentals
| Revenue (TTM) | $79.95M |
| Gross Profit (TTM) | $47.83M |
| EBITDA | $8.88M |
| Operating Margin | 21.00% |
| Return on Equity | -18.20% |
| Return on Assets | 3.59% |
| Revenue/Share (TTM) | $2.97 |
| Book Value | $0.97 |
| Price-to-Book | 26.38 |
| Price-to-Sales (TTM) | 8.63 |
| EV/Revenue | 8.69 |
| EV/EBITDA | 217.22 |
| Quarterly Earnings Growth (YoY) | -12.60% |
| Quarterly Revenue Growth (YoY) | 82.70% |
| Shares Outstanding | $27.28M |
| Float | $18.29M |
| % Insiders | 4.40% |
| % Institutions | 58.71% |
Historical Volatility
HV 10-Day
67.81%
HV 20-Day
65.71%
HV 30-Day
63.59%
HV 60-Day
55.58%
HV Rank
88.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($39.33 target)
3
BuyData last updated: 4/21/2026